On Nov 9, 2021 DNA Script closed a Grant round and raised $2,200,000 from National Human Genome Research Institute, featuring lead investors National Human Genome […]
Grant – Vasomune
On Nov 8, 2021 Vasomune closed a Grant round and raised $6,400,000 from U.S. Department of Defense, featuring lead investors U.S. Department of Defense. About […]
Series B – Platelet BioGenesis
On Nov 4, 2021 Platelet BioGenesis closed a Series B round and raised $75,500,000 from K2 HealthVentures, Oxford Finance LLC, Qiming Venture Partners, SymBiosis LLC, […]
Series A – Parthenon Therapeutics
On Nov 3, 2021 Parthenon Therapeutics closed a Series A round and raised $65,000,000 from Alexandria Venture Investments, Breakout Ventures, Creacion Ventures, KdT Ventures, Northpond […]
Series B – Prilenia
On Nov 3, 2021 Prilenia closed a Series B round and raised $43,000,000 from ALS Investment Fund, Amplitude Venture Capital, Forbion Capital Partners, Morningside Venture […]
Seed Round – Baseimmune
On Nov 2, 2021 Baseimmune closed a Seed round and raised £3,500,000 from Beast Ventures, Cherry Ventures, Creator Fund, Hoxton Ventures, Maki.vc, Rockmount Seed Investments […]
Venture Round – Shoreline Biosciences
On Nov 2, 2021 Shoreline Biosciences closed a Venture – Series Unknown round and raised $140,000,000 from Ally Bridge Group, BeiGene, Boxer Capital, BVF Partners, […]
Venture Round – Shoreline Biosciences
On Nov 2, 2021 Shoreline Biosciences closed a Venture – Series Unknown round and raised $140,000,000 from Ally Bridge Group, BeiGene, Boxer Capital, BVF Partners, […]
Series A – SimBioSys
On Oct 26, 2021 SimBioSys closed a Series A round and raised $15,000,000 from AV8 Ventures, Genoa Ventures, Heritage Group, Mayo Clinic, Northpond Ventures, featuring […]
Series C – Cambrian Biopharma
On Oct 26, 2021 Cambrian Biopharma closed a Series C round and raised $100,000,000 from Anthos Capital, Apeiron Investment Group, Future Ventures, Moore Capital, SALT […]
